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Highly conserved among species and expressed in various types of cells, numerous 
roles have been attributed to the cellular prion protein (PrPC). In hematopoiesis, 
PrPC regulates hematopoietic stem cells self-renewal but the mechanisms involved 
in this regulation are unknown. Here we show that PrPC regulates hematopoietic 
stem cells number during aging and their determination towards myeloid progenitors. 
Furthermore, PrPC protects myeloid progenitors against the cytotoxic effects of total 
body irradiation. This radioprotective effect was associated with increased cellular 
prion mRNA level and with stimulation of the DNA repair activity of the 
Apurinic/pyrimidinic endonuclease 1, a key enzyme of the base excision repair 
pathway. Altogether, these results show a previously unappreciated role of PrPC in 
adult hematopoiesis and indicate that PrPC mediated stimulation of BER activity 









Radiotherapy is commonly used alone or in combination with genotoxic drugs 
for treatment of numerous solid tumours. Despite progress in its targeting, 
radiotherapy can be deleterious to two tissues, the gastrointestinal tract and the bone 
marrow, and can lead to secondary effects commonly defined as the Acute Radiation 
Syndrome1. Irradiation of the bone marrow damages hematopoietic stem and 
progenitor cells (HSPC) and perturbs the hematopoietic microenvironment2,3  
resulting in radiation-induced acute myelosuppression4,5 and increased susceptibility 
to infections6,7. 
 Numerous types of DNA lesions are induced by ionizing radiation exposure of 
cells. They include base modifications, apurinic/apyrimidic sites (AP sites), single- 
(SSB) and double (DSB)-strand breaks. DSBs are the main lesions affecting cell 
survival. They can arise not only directly by energy deposition on the DNA but also 
as a consequence of the formation of AP sites or SSBs8,9. Indeed, base excision 
repair (BER) activities, and in particular the processing of abasic sites, have been 
shown to contribute to radiation-induced DNA damage10,11.  
AP endonuclease-1 (Ape1) is the unique enzyme that converts AP sites into 
single strand break intermediates during BER. Ape1 3’-phosphodieterase and –
phosphate activities (for review 12) also contribute to the processing of radiation-
induced DNA strand break extremities13 during the single strand break repair 
pathway (SSBR). Accordingly, protection of neuronal cells from radiation-induced 
damage requires Ape114,15. 
The Prion protein (PrPC) is a highly conserved glycoprotein that, when 
structurally modified, plays a critical role in the pathogenesis of neurodegenerative 
disorders called prion diseases16. The normal Prion protein was shown to protect 
cells from oxidative stress17–20. It also protects from DNA damage by promoting 
APE1 DNA repair activity and cell survival through an interaction with APE121. During 
hematopoiesis, PrPC is highly expressed in HSC and hematopoietic progenitors22–24 
and PrPC deficiency is associated with decreased HSC self-renewa25l. As oxidative 
stress and DNA damage act on HSC cell fate26, PrPC might participate in the 
maintenance of the hematopoietic system and its response to cytotoxic stresses. To 
address these points, we used Prnp knockout mice to study the consequences of 
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PrPC deficiency on hematopoiesis of young and old adult mice and on the response 





Mice experiments were carried out in compliance with the European Community 
Council Directive (EC/2010/63) and were approved by our Institutional ethics 
committee (CEtEA-CEA-DRF–N°17-096). The B6.129S7-Prnptm1Cwe/Orl mice were 
from the European Mutant Mouse Archive and bred in our animal facility. We also 
used Prnp ZH3/ZH3 mice provided by A. Aguzzi (Zurich, Switzerland) and C57BL/6 
mice were purchased from Charles River. 
 
Cell sorting and flow cytometry analysis of bone marrow cells.  
Murine bone marrow cells were flushed out of femurs, tibiae, hipbone and humeruses 
using a syringe filled with DPBS and filtered through a 70 µm-cell strainer. After red 
blood cell lysis using NH4Cl solution (STEMCELL Technologies), mononuclear cells 
were phenotyped using different antibody cocktails from Biolegend, e-Bioscience or 
Beckton Dickinson. Flow cytometry analysis was performed with a BD FACSLSRIITM 
flow cytometer (BD Biosciences) and cell sorting with a FACS Influx cell sorter 
(Becton Dickinson). Data were analyzed with FlowJo software. Antibodies and gating 
strategies for hematopoietic subset analysis and sorting are described in 
supplementary methods. For RT-PCR and Ape1 endonuclease activity experiments, 
aliquots of 50 000 cells myeloid progenitors were sorted in PBS whereas aliquots of 
10 000 HSC and MPP were sorted in PBS/1%BSA.  
 
Ape1 endonuclease activity 
Cell extracts were obtained by sonication of pelleted bone marrow sorted cells in 
20mM Tris-HCl, pH 7.5, 250mM NaCl, 1mM EDTA, 20mM sucrose, and protease 
inhibitor cocktail 0.1% (Sigma-Aldrich P2714). For progenitor analysis, 50 000 cells 
were suspended in 125µl extraction buffer. For HSC or MEP analysis, 10 000 sorted 
cells were suspended in 30µl extraction buffer. After sonication, the homogenate was 
centrifuged at 20 000 x g for 30 min at 4°C and aliquots of the supernatant were 
stored at -80°C. Ape1 endonuclease activity was measured using a 5’-end labelled 
34-mer oligonucleotide containing a single tetrahydrofuranyl artificial AP site at 
position 16 hybridized to its complementary oligonucleotide containing a cytosine 
opposite the lesion (Eurogentec). For measuring Ape1 activity in bone marrow 
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progenitors, 1 to 4µl of cell extract were incubated for 30min at 30°C in 10µl of 
reaction buffer containing 25mM Tris-HCl pH 7.5, 5mM MgCl2, 5% glycerol, 52mM 
NaCl, BSA 1µg/µl and 150 fmoles of the hybridized oligonucleotide. For determining 
Ape1 activity in bone marrow HSC and MPP, 1 to 4µl of cell extract were incubated 
for 10min at 30°C in 10µl reaction buffer containing 25mM Tris-HCl pH 7.5, 5mM 
MgCl2, 5% glycerol, 52mM NaCl, and 150 fmoles of the hybridized oligonucleotide.  
The reaction was stopped by adding 4µl of denaturating buffer (80 % formamide, 
0.1% bromophenol blue, 10mM EDTA) followed by heating for 5 min at 95°C. The 
products of the reaction were resolved by denaturating 7M urea-20% polyacrylamide 
gel electrophoresis. Gels were scanned using a Typhoon 5 (GE Healthcare Life 
Sciences) and band intensifies were quantified with ImageQuant TL 8.1 (GE 
Healthcare Life Sciences). 
 
Statistical analyses 
Quantitative data are presented as the mean ± sem. Statistical significance was 
assayed using the non-parametric Mann Whitney U-test (GraphPad Prism software).  
 
 





PrPC is differentially expressed in hematopoietic stem cells and myeloid progenitors 
and is involved in HSC expansion during aging  
To address the potential functions of PrPC in hematopoietic stem and progenitor 
cells (HSPC), we first characterized the expression pattern of Prnp in different 
purified hematopoietic sub-subpopulations i.e. common Myeloid Progenitors (CMP), 
Granulocyte-Monocyte Progenitors (GMP), Megakaryocyte-Erythrocyte Progenitors 
(MEP), multi-potent progenitors (MPP) and hematopoietic stem cells (HSC). The 
highest level of Prnp mRNA was found in MEP while they were 2.7-fold and 4.3-fold 
lower in CMP and GMP, respectively (Fig 1A). These differences in mRNA 
expression were also found at the protein level (Fig 1B and Fig S1A). The Prnp 
mRNA level in purified HSC was 2.5 fold higher than in MPP (Fig 1C).  
To determine if PrPC has a role in hematopoiesis, we first compared bone 
marrow (BM) from 3 months-old Prnp+/+ (WT) and Prnp-/- (KO) mice. WT and KO 
mice showed similar peripheral blood counts (data not shown) and BM cellularity (Fig 
S1B). However, the frequency of CMP, GMP and MEP was significantly reduced in 
KO mice compared to WT mice (Fig 1D), whereas CLP, MPP, ST- and LT-HSC 
frequencies were similar (Fig 1E). The differences between KO and WT myeloid 
progenitor frequencies were not associated with increased apoptosis (Fig S1C) or 
cell cycle alteration (Fig S1D) but with a higher percentage of quiescent MPP and 
ST-HSC (Fig 1F). These results suggest a defect of determination of HSPC (MPP 
and ST-HSC) towards the myeloid lineage in Prnp-/- mice. Finally, clonogenic assay 
using purified CMP and GMP showed a significantly decreased plating efficiency of 
Prnp-/- CMP and GMP (Fig 1G). Taken together, these results show intrinsic myeloid 
differentiation deficiencies in Prnp-/- HSC and progenitors and suggest that the 
reduction of cycling MPP and ST-HSC contributes to the lower myeloid progenitor 
content in the BM from KO compared to WT mice. 
Aging of HSC is associated with increased in the percentage of HSC in BM, 
decreased HSC self-renewal and accumulation of DNA damage27. As PrPC has been 
implicated in HSC self-renewal25 and in DNA repair21, we investigated the effect of 
PrPC loss in HSC numbers and DNA repair capacity during aging in Prnp+/+ and 
Prnp-/- mice. Prnp mRNA level in HSC was 2.7-fold higher in 11 months-old 
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compared to 3 months-old mice (Fig 1H) but did not change in MPP (Fig 1H). BM 
from 11 months-old WT and KO mice displayed similar cellularity (Fig S1E). As in 3 
months-old mice, a lower frequency of myeloid progenitors but not MPP (Fig 1I) was 
found in 11 months-old KO mice (Fig S1F). In contrast, compared to their 3 months-
old counterparts, ST- and LT-HSC frequencies respectively increased 2- and 8.3-fold 
in 11 months-old WT mice but did not change (ST-HSC) or was only 3-fold increased 
(LT-HSC) in 11 months-old KO mice (Fig 1I). DNA repair was slightly dependent on 
PrPC in aged HSC. A 1.4 fold increased activity of Ape1 in WT HSC was found 
between 3 months and 11 months without any change in Ape1 mRNA level. In KO 
HSC, Ape1 activity also increased between 3 months and 11 months, but to a lesser 
extent (1.2-fold) than in WT HSC. Interestingly, this increased activity was associated 
with an increased Ape1 mRNA level (Fig 1J and Fig 1K).  
Altogether, these results show that PrPC deficiency is associated with decreased 
HSC determination towards the myeloid lineage and decreased number of HSC and 
decreased APE1 activity in old mice.  
 
Prnp expression is upregulated in myeloid progenitors and HSC subpopulations after 
in vivo radiation exposure 
 
HSC aging is associated with increased oxidative stress28 and PrPC has been shown 
to protect cells from oxidative stress17–20. To characterize PrPC role during an 
oxidative stress of hematopoiesis, we performed total body irradiation (TBI) on WT 
and KO mice. Survival curves of WT and KO mice exposed to increasing gamma-
radiation doses showed that a higher percentage of irradiated KO mice died earlier 
than irradiated WT mice even if statistical significance between both genotypes was 
not reached (p=0.0792 at 7 Gy) (Fig 2A). When KO mice were grafted with BM from 
non-irradiated WT mice 24h after a 7 Gy irradiation, they did not die, indicating that 
the higher sensitivity of KO mice to TBI was not due to the bone marrow 
microenvironment of KO mice and that they died from hematopoietic syndrome. 
One hour after a 7 Gy TBI, a 1.5-fold increase of Prnp mRNA level was found 
in HSC, CMP and GMP but not in MPP and MEP (Fig 2B). These data are consistent 
with the observed Prnp upregulation in neuronal tissues after exposure to genotoxic 




PrPC-dependent increase in the DNA repair activity of Ape1 is associated with 
radioprotection of CMP and GMP 
 
PrPC prevents cell death in response to alkylating agent or H2O2 exposure by directly 
stimulating the DNA repair activity of Ape121. Without irradiation, Ape1 activity was 
similar in WT and KO progenitors (Fig 2C). One hour after a 7 Gy TBI, Ape1 activity 
increased in all WT irradiated myeloid progenitors analyzed (from 1.5 to 1.7 fold) but 
not in their KO counter parts (Fig 2D). In HSC and MPP Ape1 activity was similar in 
WT and KO mice (Fig 2E) but increased only in WT HSC after a 7 Gy TBI (Fig 2F). 
Whatever the subpopulation analyzed, the radiation-induced Ape1 activity was not 
associated with an increase in Ape1 mRNA level (Fig S2A and S2B). These data 
show that after irradiation, Ape1 activity in all myeloid progenitor subpopulations and 
in HSC is stimulated in a PrPC-dependent manner. 
 As the radiation-induced death of myeloid progenitors is dependent on 
apoptosis5, we quantified apoptosis in WT and KO myeloid progenitors one and 
twelve hours after TBI at 7 Gy. One hour after irradiation, apoptotic (Annexin V-
positive cells) and dead cells (Annexin V-negative and Hoechst-positive cells) 
fractions increased only in CMP and were higher in KO compared to WT CMP (Fig 
2G and S2C). Twelve hours after irradiation, both apoptotic (Fig 2H) and dead (Fig 
S2D) cells fractions increased in all myeloid progenitor subpopulations in both WT 
and KO mice.  However, higher rates of apoptosis and cellular death were observed 
in irradiated KO compared to WT GMP. In accordance, significantly lower 
frequencies of CMP and GMP were found in KO versus WT irradiated mice 18h after 
irradiation (Fig 2I). Myeloid progenitors from Prnp ZH3/ZH3 mice exhibited the same 
radiation sensitivity than those from Prnp-/- mice shown by a similar reduced number 
compared to mice in non-irradiated conditions (Fig S2 E). Altogether these results 
suggest that PrPC-dependent stimulation of the DNA repair activity of Ape1 is 




Despite numerous studies, the physiological role of PrPC remains elusive. 
Recently, we showed that PrPC can stimulate an important DNA repair pathway, the 
BER, in neuronal tissues through interaction with and stimulation of its key enzyme, 
APE121. Here we show that the same mechanism can be proposed for the 
radioprotection of myeloid progenitors, HSC determination, and the expansion of the 
HSC compartment during aging.  
Previous studies22–24,29 indicated a decreased Prnp expression during 
differentiation of hematopoietic cells. Here, we performed an extended study of Prnp 
expression in different hematopoietic sub-populations and showed a 3-fold higher 
Prnp expression level in MEPs compared to their progenitors CMP suggesting that 
the correlation between Prnp downregulation and cellular differentiation24 may not be 
a general feature in hematopoiesis. Furthermore, and contrary to a previous study25, 
we found that KO mice have less myeloid progenitors. This discrepancy could be 
explained by the fact that in the previous study younger mice were analyzed (7 to 10 
weeks-old mice compared to 3 months- and 11 months-old mice used in the present 
study) and by the number of backcrosses (4 versus >10) that might influence the 
phenotype of Prnp knockout mice30. Finally, we found a higher frequency of KO ST-
HSC and KO MPP in the G0 phase. These populations being the direct precursors of 
myeloid progenitors, the increased quiescence of these cells might account for the 
decreased myeloid progenitor subpopulations31. Strinkingly, both KO CMP and GMP 
exhibited a lower plating efficiency despite no significant change in their cell cycle in 
vivo. Whether the microenvironment of these cells could compensate in vivo for an 
intrinsic growth deficiency observed in vitro remains to be clarified. 
Prnp expression in the HSC compartment increased 8-fold with age. This 
higher expression was associated with the known elevated frequency of both ST- 
and LT-HSC27,32. PrpC deficiency was associated with no increase of ST-HSC and 
with a diminished increase of LT-HSC with age suggesting that PrPC plays a role in 
the age-dependent increase of HSC. Although aging-associated increase in HSC 
numbers has been known for a long time and is known to be cell-intrinsic33,34, the 
underlying mechanisms are not fully understood. The results presented here indicate 
a significant involvement of PrPC in the age-dependent increase of HSC frequency. 
This increase may be accounted for by a PrPC-dependent up-regulation of Ape1 
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repair activity. Independent from its DNA repair activity35,36. Ape1 has a redox activity 
shown to be necessary for normal embryonic hematopoiesis37, stem cell pool 
maintenance38,39 and hematopoietic progenitors colony formation40. Thus, the PrPC-
dependent stimulation of the APE1 DNA repair activity might contribute to 
hematopoietic homeostasis.  
 We found a modest but recurrent radiation sensitization of Prnp KO mice that 
contrasts with a previous study showing that the absence of PrPC protected rather 
than sensitized mice to an 8 Gy TBI41. However, this work was performed on a mixed 
129/C57BL6 background, whereas we used a pure C57BL6 background. 
Furthermore, that study used a dose of X-rays that was lethal for WT animals while 
we used different doses of non-lethal γ-rays. Bone marrow myeloid cells are 
particularly sensitive to chemical and radiation cytotoxicity4,42,43. Accordingly, we 
found a dramatic decrease in bone marrow myeloid progenitors within the first 24h 
after radiation exposure that was exacerbated in Prnp KO irradiated mice. The 
reduced frequency of KO irradiated myeloid progenitors was associated with higher 
CMP and GMP apoptosis, within the first twelve hours after irradiation, as well as 
with an absence of stimulation of APE1 activity in these subpopulations one hour 
after irradiation. In contrast, in WT irradiated myeloid progenitors and HSC, 
upregulation of Prnp gene expression was associated with an increase in Ape1 
activity in these sub-populations. PrPC has been shown to protect HSC from 
myelotoxic injury by 5-FU, commonly used in chemotherapy25 and we now extend its 
myeloprotective role to radiotherapy. 
Finally, a similar basal reduced number of myeloid progenitors and a similar 
radiation sensitivity of myeloid progenitors were found in the co-isogenic Prnp ZH3/ZH3 
mouse line44 and the Prnp-/- mouse line. These results rule out the involvement of 
any Prnp flanking genes polymorphism previously described by Nuvolone et al45.  
Altogether, these results suggest that PrPC is involved in the homeostasis of 
steady-state hematopoiesis and that PrPC dependent activation of base excision 
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Fig1: PrPC contributes to mouse hematopoietic homeostasis.  
(A) qRT-PCR analysis of Prnp expression, normalized to Rplp0 in the indicated bone 
marrow sub-populations: CMP, common myeloid progenitor; GMP, granulocyte-
macrophage progenitor; MEP, megakaryocyte-erythrocyte progenitor purified by flow 
cytometry from BM of 3 months-old mice (n=7-9). Data are presented as mean±SEM. 
Means with different letters are significantly different (P<0.05).  
(B) Flow cytometry analysis of the PrPC protein expression in the indicated bone 
marrow supopulations. The graph depicts ratio of median fluorescence intensity 
(MFI) in WT and KO control cells (n=5-6). Data are presented as mean±SEM. Means 
with different letters are significantly different (P<0.05) (CMP versus MEP p=0.06).  
(C) qRT-PCR analysis of Prnp expression, normalized to Actb in HSC, hematopoietic 
stem cell (LSK CD135-) and in MPP, multipotent progenitor (LSK CD135+) purified by 
flow cytometry from BM of 3 months-old mice (n=9); Data are presented as 
mean±SEM. Statistically significant difference between HSC and MPP is indicated by 
asterisks (*** P<0.001).  
(D) Frequencies of myeloid progenitors in WT (black bars) and KO (white bars) bone 
marrow from 3 months-old mice (n=6-10). Data are presented as mean±SEM. 
Statistically significant differences between WT and KO are indicated by asterisks (* 
P<0.05; **P<0.01). 
(E) Frequencies of lymphoid progenitors (CLP), MPP, ST- and LT-HSC in the bone 
marrow from WT (black bars) and KO (white bars) mice (n=6). Data are presented as 
mean±SEM. 
(F) Distribution of WT (black bars) and KO (white bars) HSC and MPP in each phase 
of the cell cycle. Data are presented as mean±SEM. Statistically significant 
differences between WT and KO are indicated by asterisks (* P< 0.05; ** P<0.01).  
(G) In vitro plating efficiency of CMP and GMP purified by flow cytometry from BM of 
WT (black bars) and KO (white bars) mice (n=6-9). Data are presented as 
mean±SEM. Statistically significant differences between WT and KO are indicated by 
asterisks (** P<0.01). 
(H) qRT-PCR analysis of Prnp expression, normalized to Actb in WT and KO HSC 
and MPP purified by flow cytometry from bone marrow of 3 months and 11 months 
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old mice (n=6-9). Data are presented as the mean±SEM. Statistically significant 
differences between 3 and 11 months-old mice and between HSC and MMP 
subpopulations are indicated by hash signs and asterisks, respectively (*** or ### 
P<0.001)  
(I) Frequencies of MPP, ST- and LT-HSC in BM from 3 months and 11 months old 
WT (black bars) and KO (white bars) mice. Data are presented as the mean±SEM 
fold change of the frequencies in 11 months relative to 3 months-old mice. 
Statistically significant differences according to age or genotype are indicated by 
asterisks and hash signs, respectively (n=6-10; ** or ## P<0.01). 
J) Ape1 endonuclease activity in 3 (opened) and 11 (hatched) months-old WT (dark) 
and KO (light) HSC. Data are presented as the mean±SEM. Statistically significant 
differences according to age or genotype are indicated by asterisks and hash signs, 
respectively (n=4-5; * or # P<0.05). 
K) qRT-PCR analysis of Ape1 expression, normalized to Actb in WT (dark) and KO 
(light) HSC purified by flow cytometry from bone marrow of 3 (opened bars) and 11 
(hatched bars) months-old mice. Data are presented as the mean±SEM. Statistically 
significant differences according to age or genotype are indicated by asterisks and 
hash signs, respectively (n=7-9; * or # P<0.05). 
 
 
Fig 2: PrPC favours survival of mice exposed to moderate doses of γ-rays and 
protects CMP from radiation-induced death.  
(A) Kaplan-Meier survival plots of WT (solid lines) and KO (dashed lines) mouse 
overall survival after whole-body irradiation at indicated doses (n= 5 (10 Gy); n=13 
(6.5 Gy); n= 28 (7 Gy) for each genotype). The arrow points to the 100% survival of 
both KO and WT irradiated mice (7 Gy) after transplantation of WT bone marrow 
cells (n=5). 
(B) qRT-PCR analysis of Prnp expression in HSC, MPP and myeloid progenitors one 
hour after irradiation (7 Gy) (n=6). Prnp RNA levels were normalized to Actb (HSC 
and MPP) or Rplp0 (myeloid progenitors). Data are presented as the mean±SEM fold 
change of normalized Prnp RNA levels in irradiated relative to control cells. 
Statistically significant differences between irradiated and control are indicated by 
asterisks (* P<0.05; ** P<0.01).  
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(C) Ape1 endonuclease activity in myeloid progenitor subpopulations from WT (black 
bars) and KO (white bars) mice (n=5-8).  Data are presented as the mean±SEM. 
Means with different letters are significantly different (P<0.05). 
(D) Ape1 endonuclease activity in myeloid progenitors from WT (black bars) and KO 
(white bars) mice (n=5-8) one hour after irradiation (7 Gy). Data are presented as the 
mean±SEM fold change of Ape1 endonuclease in irradiated relative to non-irradiated 
control cells. Statistically significant differences between non-irradiated and irradiated 
cells are indicated by asterisks (* P<0.05; ** P<0.01).  
(E) Ape1 endonuclease activity in HSC and MPP from WT (black bars) and KO 
(white bars) mice (n=5-8). Data are presented as the mean±SEM. 
(F) Ape1 endonuclease activity in HSC and MPP from WT (black bars) and KO 
(white bars) mice (n=4-5) one hour after irradiation (7 Gy). Data are presented as the 
mean±SEM fold change of Ape1 endonuclease in irradiated relative to non-irradiated 
control cells. Statistically significant differences according to treatment or genotype 
are indicated by an asterisk and hash sign, respectively (* or # P<0.05).  
(G) Percentage of apoptotic myeloid progenitors (AnnexineV-positive cells) in BM 
from WT (black bars) and KO (white bars) mice (n=6-8) 1h after irradiation (7 Gy). 
Data are presented as the mean±SEM fold change of percentage of apoptotic cells in 
irradiated relative to non-irradiated control myeloid progenitors. Statistically 
significant differences according to treatment or genotype are indicated by asterisks 
(*) and hash signs, respectively (** P<0.01; *** P<0.001; # P<0.05). 
(H) Percentage of apoptotic myeloid progenitors (AnnexineV-positive cells) in BM 
from WT (dark gray bars - WTIR) and KO (light gray bars - KOIR) mice (n=6-8) 1h 
after irradiation (7 Gy). Data are presented as the mean±SEM.  Non-irradiated 
control WT (black bars) and KO (white bars) myeloid progenitors are shown. 
Statistically significant differences according to treatment or genotype are indicated 
by asterisks (*) and hash signs, respectively (** P<0.01; # P<0.05). 
(I) Percentage of myeloid progenitors in BM from WT (black bars) and KO (white 
bars) mice (n=6-7) 18h after irradiation (7 Gy). Data are presented as the mean±SEM 
of the percentage of cells remaining in BM 18h after irradiation compared to non-
irradiated control. Statistically significant differences between WT and KO mice are 
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